What are the target supine, sitting, and standing blood pressure (BP) goals for this patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Pressure Goals by Position

For most patients with hypertension, blood pressure should be measured and targeted in the sitting position, with a goal of 120-129/70-79 mmHg if tolerated, but standing BP must also be checked to screen for orthostatic hypotension. 1

Primary BP Target: Sitting Position

The sitting position is the standard measurement position for blood pressure targets in clinical practice. 2

  • Initial target: <140/90 mmHg for all hypertensive patients 1, 2
  • Optimal target: 120-129/70-79 mmHg if treatment is well tolerated, with 120 mmHg being the optimal systolic point in this range 1, 2
  • For diabetes: Target systolic BP to 130 mmHg and <130 mmHg if tolerated, but not <120 mmHg 1
  • For chronic kidney disease: 120-129 mmHg systolic if eGFR >30 mL/min/1.73 m² and treatment is tolerated 1

Supine BP Considerations

Supine BP is not routinely used as a treatment target but should be measured when assessing for orthostatic hypotension. 3

  • Supine measurements are primarily used to calculate the drop in BP when transitioning to standing 3
  • No specific supine BP target exists in guidelines; the focus is on detecting excessive drops upon standing 3

Standing BP: Critical Safety Monitoring

Standing BP must be checked to identify orthostatic hypotension, which is a contraindication to aggressive BP lowering. 1, 3

  • Measure BP after 1-3 minutes of standing to assess for orthostatic hypotension 3
  • A drop of ≥20 mmHg systolic or ≥10 mmHg diastolic indicates orthostatic hypotension 3
  • Patients with pre-treatment symptomatic orthostatic hypotension should have more lenient BP targets and follow the "as low as reasonably achievable" (ALARA) principle 1

Special Population Modifications

Elderly Patients (≥65 years)

  • Ages 65-79: Target 130-139/70-79 mmHg in sitting position 1, 4
  • Ages ≥80: Target 130-139 mmHg systolic, with more lenient targets (up to 140-150 mmHg) acceptable if lower targets not tolerated 1, 4
  • Ages ≥85 or with significant frailty: Target systolic BP "as low as reasonably achievable" rather than rigid 120-129 mmHg goal 1, 4
  • Critical caveat: Diastolic BP should not fall below 60-70 mmHg in elderly patients due to risk of coronary hypoperfusion 4, 2

High-Risk Patients

  • Patients with established cardiovascular disease, diabetes, or chronic kidney disease should target <130/80 mmHg in sitting position 1, 2
  • Those with proteinuria (protein-creatinine ratio >500 mg/g) should target <130 mmHg systolic for renal protection 1

Measurement Technique Requirements

All BP measurements should use validated automated upper arm cuff devices with appropriate cuff size. 2, 3

  • Take average of at least 2 readings per visit 2
  • Measure in both arms at first visit; use arm with higher readings for subsequent measurements 2
  • Patient should be seated with back supported, feet flat on floor, arm at heart level 2

Common Pitfalls to Avoid

  • Do not ignore standing BP: Failure to check for orthostatic hypotension can lead to falls, syncope, and adverse events with aggressive BP lowering 1, 3
  • Do not push diastolic BP below 60 mmHg: This increases cardiovascular risk, particularly in elderly patients and those with coronary disease 4, 2
  • Do not apply intensive targets to frail elderly: Patients ≥85 years or with significant frailty may not tolerate BP <130 mmHg and should have individualized, more lenient targets 1, 4
  • Beware of the "white coat effect": Confirm office BP measurements with home BP monitoring (target <135/85 mmHg) or 24-hour ambulatory monitoring (target <130/80 mmHg) 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Blood Pressure Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Blood Pressure Monitoring Guidelines for Guanfacine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Blood Pressure Management in the Elderly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the target blood pressure (BP) for a young patient with hypertension and impaired renal function?
What are the Canadian guidelines for hypertension management, including blood pressure (BP) targets and treatment options?
What is the next step in managing a 30-year-old male with hypertension (high blood pressure), anemia (low hemoglobin), impaired renal function (elevated creatinine), and elevated liver enzymes (SGPT and SGOT), with a hemoglobin level of 8 g/dL, mean corpuscular volume (MCV) of 62 fL, and red cell distribution width (RDW) of 19.6%?
What are the best initial antihypertensive medications, including dosage and potential combinations, for a patient with hypertension, considering various comorbid conditions and aiming for a blood pressure goal of less than 130/80 mmHg?
What are the Canadian goals of therapy for hypertension?
What is the role of a healthcare provider regarding anxiety?
Is a bilateral L4-5, L5-S1 facet joint injection medically necessary for a 61-year-old male with spondylosis (degenerative joint disease) without myelopathy (spinal cord damage) or radiculopathy (nerve root damage) in the lumbosacral region, who has shown improvement with previous transforaminal epidural steroid injections (TFESI) and has symptoms consistent with facet joint syndrome?
How can I maintain good arterial health?
What is the best treatment approach for chronic diarrhea in an elderly male nutrition patient?
What are the physiological and psychological signs and symptoms of Level I Anxiety?
What is the recommended intravenous (IV) dosage of ondansetron for pediatric patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.